Breaking News
September 25, 2018 - New therapeutic vaccine helps immune cells fight HPV-related head and neck cancer
September 25, 2018 - Environmentally-induced gene activity influences IQ test performance
September 25, 2018 - Biogen and Eisai announce results of LTE Phase 1b study of aducanumab for treating MCI
September 25, 2018 - FDA Approves Copiktra (duvelisib) Capsules for Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma and Follicular Lymphoma
September 25, 2018 - Medical device company settles US case over false claims
September 25, 2018 - Trying to get answers: One woman’s quest for a diagnosis
September 25, 2018 - Lung cancer patients treated with invasive surgery more likely to become chronic opioid users
September 25, 2018 - Oxford VR raises £3.2m to boost innovation in VR for mental health problems
September 25, 2018 - Gene therapy approach could help treat mitochondrial diseases
September 25, 2018 - Few Yogurt Products Qualify As Low-Sugar
September 25, 2018 - Eye disease can cause blindness, and it’s on the rise
September 25, 2018 - Pawnshop density linked to gun-related suicides, Stanford study finds
September 25, 2018 - Pioneering procedure for common prostate condition offered by The London Clinic
September 25, 2018 - Number of people with respiratory diseases likely to increase if UK air pollution remains unchecked
September 25, 2018 - FARXIGA receives positive results in Phase III DECLARE-TIMI 58 cardiovascular outcomes trial
September 25, 2018 - New program to reduce harmful stress effectively improves mood in cancer patients
September 24, 2018 - Florence’s Lingering Threat: Mold – Drugs.com MedNews
September 24, 2018 - For professional baseball players, faster hand-eye coordination linked to batting performance
September 24, 2018 - Bill for later school start times is defeated, but Stanford sleep specialist isn’t
September 24, 2018 - For Heart Failure Patients, Mitral Valve Procedure Improved Outcomes
September 24, 2018 - Successful recovery from addiction means more than achieving abstinence
September 24, 2018 - New nanoplatform technology may reverse drug-resistance in renal cell carcinoma
September 24, 2018 - October 1918 marks the centenary of Spanish Flu that claimed more lives than World War I
September 24, 2018 - LGBT community reports more number of poor mental health days than general population
September 24, 2018 - New research suggests power of zebrafish as tool for cancer drug discovery
September 24, 2018 - New study finds height as possible risk factor for developing varicose veins
September 24, 2018 - Researchers compare weight loss results of online and in-person diabetes prevention program
September 24, 2018 - New HER2 PET Study Uses Affibody’s ABY-025 Tracer to Individualize Breast Cancer Treatment
September 24, 2018 - Drug combination offers more effective care for patients suffering miscarriage
September 24, 2018 - Tallness linked to varicose veins, Stanford study says
September 24, 2018 - For Heart Failure Patients, Mitral Valve Procedure Improved Outcomes
September 24, 2018 - Ecstasy drug makes octopuses more social
September 24, 2018 - Immediate compression therapy could cut risk of complications after deep-vein thrombosis
September 24, 2018 - Transcatheter mitral valve repair reduces mortality for patients with mitral regurgitation
September 24, 2018 - First intracranial aneurysm patients treated with BRAVO Flow Diverter after CE mark approval
September 24, 2018 - ‘Physicians of the mouth’? Dentists absorb the medical billing drill
September 24, 2018 - People more likely to believe those with confident tone of voice than with accent
September 24, 2018 - Harmony Biosciences Presents 5-Year Data On Pitolisant At International Narcolepsy Symposium
September 24, 2018 - Blood test may identify gestational diabetes risk in first trimester
September 24, 2018 - Height may be risk factor for varicose veins | News Center
September 24, 2018 - King’s commemorates opening of new NMR facility with one-day symposium
September 24, 2018 - Eisai receives approval for partial label change of DC Bead device for transcatheter arterial embolization
September 24, 2018 - Using multi-level approach to reduce underage drinking among youths on rural reservations
September 24, 2018 - High-resolution genomic map gives scientists unprecedented view of brain development
September 24, 2018 - Researchers find impact of neurobehavioral symptoms on employment in adults with TBI
September 24, 2018 - Alexion announces positive results from Phase 3 PREVENT study of Soliris in patients with NMOSD
September 24, 2018 - First evaluation of benefits, harms of Alzheimer’s screening for family members of older adults
September 24, 2018 - Ancora Heart announces positive data of study evaluating AccuCinch Ventricular Repair System
September 24, 2018 - Children of mothers using cannabis may start using it at an earlier age, finds study
September 24, 2018 - Gilead Sciences plans to launch authorized generic versions of Epclusa and Harvoni in the US
September 24, 2018 - Most patients who underwent transcatheter valve replacement experience prosthesis-patient mismatch
September 24, 2018 - Lumos acquires license for LUM-201 drug that promotes secretion of growth hormone
September 24, 2018 - New study provides basis for Air Canada to change its facial hair policy for aircrew
September 24, 2018 - Infant walkers lead to thousands of emergency visits for babies
September 24, 2018 - Genes predicting person’s height may provide clues about causes of varicose veins
September 24, 2018 - EPA Plan Will Maintain Carbon Emissions From Power Plants
September 24, 2018 - Characterizing pig hippocampus could improve translational neuroscience
September 24, 2018 - Element3 Health reports social and mental engagement play key role in overall health
September 24, 2018 - Paralympic medalists support Fight for Sight’s unique virtual event
September 24, 2018 - ADCETRIS drug receives approval in Japan as frontline treatment option for Hodgkin lymphoma
September 24, 2018 - Public awareness of urological conditions found to be alarmingly low across Europe
September 24, 2018 - Fitter Folks Suffer Milder Strokes: Study
September 24, 2018 - Novel botulinum toxin compound relieves chronic pain
September 24, 2018 - CHMP recommends approval of Gilenya for treatment of multiple sclerosis in children, adolescents
September 24, 2018 - National Friendly’s private medical insurance is a hit with women living in the South East
September 24, 2018 - Academics receive prestigious awards for achievements in blood pressure research
September 24, 2018 - Obese pregnant women can restrict weight gain safely with proper nutrition guidance
September 24, 2018 - CHMP adopts positive opinion of Takeda’s ALUNBRIG for treatment of ALK+ non-small cell lung cancer
September 24, 2018 - China NMPA approves LENVIMA for treatment of unresectable hepatocellular carcinoma
September 24, 2018 - A new approach for finding Alzheimer’s treatments
September 24, 2018 - USC research uncovers previously unknown genetic risk factor for dementia
September 24, 2018 - Study examining mental health among students finds significant disparities in treatment across race
September 24, 2018 - Breakthrough discovery paves way for future test to identify drowsy drivers
September 24, 2018 - Transcatheter mitral-valve repair in patients with heart failure
September 24, 2018 - Study opens new avenues for treatment of Laing distal myopathy
September 24, 2018 - Stroke Facts | cdc.gov
September 24, 2018 - Sarcolipin tricks muscle cells into using more energy, burning fat
September 24, 2018 - Enrollment in opioid controlled substance agreement reduces primary care visits
September 24, 2018 - UTA researchers patent new smart seat cushion technology that helps prevent painful ulcers
September 24, 2018 - Second HPV-Related Primary Cancers Common in Survivors
HIV Diagnoses Occurring More Quickly, CDC Says: MedlinePlus Health News

HIV Diagnoses Occurring More Quickly, CDC Says: MedlinePlus Health News

image_pdfDownload PDFimage_print

HealthDay news image

TUESDAY, Nov. 28, 2017 (HealthDay News) — U.S. health care providers are getting better at detecting new cases of HIV infection, although it still can take years for people to know they’ve acquired the dreaded virus, federal officials reported Tuesday.

The average time between HIV infection and diagnosis was three years in 2015, seven months earlier than it had been in 2011, according to researchers from the U.S. Centers for Disease Control and Prevention.

A seven-month improvement in four years is a considerable decrease and shows that the United States is on the right track, the CDC said.

“Overall, it reveals that we as a nation are making great progress in HIV prevention,” Dr. Brenda Fitzgerald, the CDC director, said during a news briefing on the newly released data.

“These findings are more encouraging signs that the tide continues to turn on our nation’s HIV epidemic,” she said earlier in a prepared statement. “HIV is being diagnosed more quickly, the number of people who have the virus under control is up and annual infections are down. So while we celebrate our progress, we pledge to work together to end this epidemic forever.”

The CDC report was based on HIV surveillance data from all 50 states and more than 20 large cities.

Overall, 85 percent of the estimated 1.1 million people living with HIV in the United States in 2014 knew they were infected. The CDC estimates that people unaware of their HIV status are responsible for about 40 percent of new infections.

In particular, it appears that efforts to get high-risk people tested for HIV are paying off. Groups that more frequently reported getting a recent HIV test included:

  • Gay men (from 63 percent tested in 2008 to 71 percent in 2014).
  • People who inject drugs (from 50 percent in 2009 to 58 percent in 2015).
  • Heterosexuals at increased risk for infection (from 34 percent in 2010 to 41 percent in 2016).

However, that still leaves large numbers of at-risk people who are not getting tested, CDC officials noted.

The CDC recommends that all teenagers and adults be tested for HIV at least once during their lifetime, and people in high-risk groups should be tested at least annually.

But, Fitzgerald said, “we also know we are still missing opportunities for testing people most at risk for HIV.”

The study revealed that seven in 10 people at high risk for HIV infection saw a health care provider in the past year but did not get tested, signaling a missed opportunity.

Testing is key to preventing the spread of HIV, the CDC researchers explained. One-quarter of people diagnosed with HIV in 2015 carried the virus for seven or more years without knowing it.

“If you are at risk for HIV, don’t guess — get a test,” Dr. Jonathan Mermin, director of the CDC’s National Center for HIV/AIDS, Viral Hepatitis, STD and TB Prevention, said in the CDC statement. “The benefits are clear. Prompt diagnosis is prevention. It is the first step to protecting people living with HIV and their partners.”

Once diagnosed, people can be treated with drugs that suppress HIV down to nearly undetectable levels in their blood, he added during the news briefing.

“In recent studies of thousands of couples where one partner has HIV and the other does not, there have been no sexually transmitted HIV infections when the HIV-positive partner was virally suppressed,” Mermin said.

Lack of prompt testing varies based on a person’s race or ethnicity and the risk group to which they belong, according to the CDC. For instance:

  • Gay and bisexual males received their HIV diagnosis three years after infection, on average, compared with five years for heterosexual men and 2½ years for women.
  • White people tended to be diagnosed an average of two years after infection, compared with three years for blacks and Hispanics, and four years for Asian-Americans.

Fitzgerald added, “Once diagnosed, HIV can be treated so people who have HIV can live long, healthy lives.”

The findings were published Nov. 28 in the CDC’s Morbidity and Mortality Weekly Report.

SOURCES: U.S. Centers for Disease Control and Prevention, news briefing with Brenda Fitzgerald, M.D., CDC director, and Jonathan Mermin, M.D., director of the CDC’s National Center for HIV/AIDS, Viral Hepatitis, STD and TB Prevention; Nov. 28, 2017, news release, U.S. Centers for Disease Control and Prevention; Nov. 28, 2017, Morbidity and Mortality Weekly Report

News stories are written and provided by HealthDay and do not reflect federal policy, the views of MedlinePlus, the National Library of Medicine, the National Institutes of Health, or the U.S. Department of Health and Human Services.

Tagged with:

About author

Related Articles